IJR News — today's news from every side

IJR News — today's news from every side

blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

Loading

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

© OpenServe Holdings LLC

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News
Encouragement
Video
Meme Wars

Brands

Yourlist
Quizie
FaithTap
Blessed
All brands

📊 Approval moversGordon Liu100%

Hims & Hers Faces Investor Class Action, Lead DeadlineBusiness — Sep 12, 2026Multiple lawsuits and regulatory actions have targeted Hims & Hers Health, with the FTC alleging deceptive privacy and billing practices and improper sharing of health data with third parties, contributing to a notable stock drop after the July 29, 2026 announcement. Separately, investors are urged to participate in lead-plaintiff processes for securities-class actions, as several institutions increased holdings or sold, and deadlines for filing lead plaintiff applications remain November 2, 2026.

FDA crackdown on unapproved GLP-1 weight-loss drugsHealth — Aug 31, 2026FDA warnings highlight severe health risks from unapproved compounded GLP-1 weight-loss drugs, including hospitalizations and contamination, as enforcement tightens import controls. Meanwhile, Hims & Hers is expanding internationally with branded GLP-1 treatments in Australia after acquiring Eucalyptus, signaling aggressive global growth toward a $6.5 billion revenue target by 2030 amid rising digital-health competition.